Journal article

Specific inhibition of the eubacterial DNA ligase by arylamino compounds

G Ciarrocchi, DG Macphee, LW Deady, L Tilley

Antimicrobial Agents and Chemotherapy | AMER SOC MICROBIOLOGY | Published : 1999

Abstract

All known DNA ligases catalyze the formation of a phosphodiester linkage between adjacent termini in double-stranded DNA via very similar mechanisms. The ligase family can, however, be divided into two classes: eubacterial ligases, which require NAD+ as a cofactor, and other ligases, from viruses, archaea, and eukaryotes, which use ATP. Drugs that discriminate between DNA ligases from different sources may have antieubacterial activity. We now report that a group of arylamino compounds, including some commonly used antimalarial and anti-inflammatory drugs and a novel series of bisquinoline compounds, are specific inhibitors of eubacterial DNA ligases. Members of this group of inhibitors have..

View full abstract

University of Melbourne Researchers